Moreover, CD40LG has a strong anti-tumor effect on HCC and other malignant tumors (36), while the CD40LG-CD40L interaction has been shown to overcome tumor-specific CD4+ and CD8+ tolerance and thus induce anti-tumor immunity (37). Here, CD4 is linked to hepatocellular carcinoma.